Junsai Shengwu
Shanghai
About Junsai Shengwu
Junsai Shengwu is a biotechnology company that develops novel therapeutic approaches for new solid tumor cell .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $42.9M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2025)
- Website: juncell.com
- Phone: +86 021-69110327
Industries & Categories
Biopharma, Clinical Trials, Pharmaceutical
Canonical: https://fsome.com/organization/junsai-shengwu-21742 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.